Tepezza hearing loss litigation — safety… | DrugsMonitor.com

Clinical summary and reported injury patterns for Tepezza hearing loss litigation. Links to FDA recalls and litigation overview. Not medical advice.

teprotumumab, thyroid eye disease, tinnitus, sensorineural hearing loss

Clinical context

Se alega que el teprotumumab para la enfermedad ocular de la tiroides causa pérdida auditiva permanente y tinnitus en algunos pacientes.

Litigation context

MDL No. 3079 en el Distrito Norte de Illinois; descubrimiento en curso.